GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alpa Laboratories Ltd (NSE:ALPA) » Definitions » Cyclically Adjusted Revenue per Share

Alpa Laboratories (NSE:ALPA) Cyclically Adjusted Revenue per Share : ₹50.21 (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Alpa Laboratories Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Alpa Laboratories's adjusted revenue per share for the three months ended in Dec. 2023 was ₹13.142. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹50.21 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Alpa Laboratories's average Cyclically Adjusted Revenue Growth Rate was 5.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2024-05-26), Alpa Laboratories's current stock price is ₹89.30. Alpa Laboratories's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was ₹50.21. Alpa Laboratories's Cyclically Adjusted PS Ratio of today is 1.78.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Alpa Laboratories was 2.22. The lowest was 1.11. And the median was 1.49.


Alpa Laboratories Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Alpa Laboratories's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alpa Laboratories Cyclically Adjusted Revenue per Share Chart

Alpa Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 48.41

Alpa Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 47.84 48.41 49.38 50.14 50.21

Competitive Comparison of Alpa Laboratories's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Alpa Laboratories's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alpa Laboratories's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alpa Laboratories's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Alpa Laboratories's Cyclically Adjusted PS Ratio falls into.



Alpa Laboratories Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Alpa Laboratories's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=13.142/152.9243*152.9243
=13.142

Current CPI (Dec. 2023) = 152.9243.

Alpa Laboratories Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201203 6.974 76.889 13.871
201206 6.282 79.567 12.074
201209 5.669 82.244 10.541
201212 5.712 83.774 10.427
201303 9.129 85.687 16.292
201306 4.645 88.365 8.039
201309 6.529 91.042 10.967
201312 6.878 91.425 11.505
201403 8.838 91.425 14.783
201406 4.786 94.103 7.778
201409 9.075 96.780 14.340
201412 6.543 96.780 10.339
201503 6.716 97.163 10.570
201506 3.927 99.841 6.015
201509 5.957 101.753 8.953
201603 0.000 102.518 0.000
201703 0.000 105.196 0.000
201803 0.000 109.786 0.000
201809 7.173 115.142 9.527
201812 12.340 115.142 16.389
201903 6.538 118.202 8.459
201906 9.648 120.880 12.206
201909 11.175 123.175 13.874
201912 11.504 126.235 13.936
202003 18.836 124.705 23.098
202006 7.760 127.000 9.344
202009 11.559 130.118 13.585
202012 15.739 130.889 18.389
202103 11.298 131.771 13.112
202106 14.933 134.084 17.031
202109 12.492 135.847 14.062
202112 13.937 138.161 15.426
202203 11.113 138.822 12.242
202206 10.699 142.347 11.494
202209 6.705 144.661 7.088
202212 12.965 145.763 13.602
202303 13.767 146.865 14.335
202306 12.073 150.280 12.285
202309 15.388 151.492 15.533
202312 13.142 152.924 13.142

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Alpa Laboratories  (NSE:ALPA) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Alpa Laboratories's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=89.30/50.21
=1.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Alpa Laboratories was 2.22. The lowest was 1.11. And the median was 1.49.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Alpa Laboratories Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Alpa Laboratories's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Alpa Laboratories (NSE:ALPA) Business Description

Industry
Traded in Other Exchanges
Address
33/2, A.B. Road, Pigdamber, Rau, Indore, MP, IND, 453446
Alpa Laboratories Ltd is an India-based pharmaceutical company. It operates in the business segment of Drugs and Chemicals. The company manufactures and markets pharmaceuticals and related products. It sells products like liquid injection, dry powder injection, tablets, capsules, and ointments.